1. Bregant, F., Pacor, S., Ghosh, S. (1993) Effects of some ruthenium chelates on MCa mammary carcinoma and on TLX5 lymphoma in mice. Anticancer Res., 13, 1007–1010.
2. Cauci, S., Alessio, E., Mestroni, G. and Quadrifoglio, F. (1987) Reaction of cis-RuII(DMSO)4Cl2 with DNA and with some of its bases in aqueous solution. Inorg. Chim. Acta, 137, 19–24.
3. Chan, P. K. L., Skov, K. A., James, B. R. and Farrell, N. P. (1986) A new ruthenium radiosensitizer: RuCl2(DMSO)2(4-nitroimidazole)2. Int. J. Rad. Oncol. Biol. Phys., 12, 1059–1062.
4. Clarke, M. J. (1980) Oncological implications of the chemistry of ruthenium, in Metal Ions in Biological Systems, (ed. H. Sigel), Vol. 11, Marcel Dekker, New York, pp. 231–283.
5. Clarke, M. J. (1989) Ruthenium chemistry pertaining to the design of anticancer agents, in Progress in Clinical Biochemistry and Medicine-Non-platinum Metal Complexes in Cancer Chemotherapy(ed. M. J. Clarke), Springer-Verlag, Berlin, pp. 25–39.